SCHEMBL5031070

SCHEMBL5031070

CCCOCC(O[SiH3])(OCCC)OCCC

nearest known ligand 0.30

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4141620 0.87 HSD17B10 (0.33) HSD17B10
SCHEMBL855728 0.82 TSHR (0.38)
SCHEMBL7753980 0.81 HSD17B10 (0.30) HSD17B10
SCHEMBL3194364 0.80
SCHEMBL15415199 0.78
SCHEMBL30096455 0.76
SCHEMBL5031069 0.75
SCHEMBL4753806 0.73 HSD17B10 (0.31) HSD17B10
SCHEMBL11792662 0.70 TSHR (0.40)
SCHEMBL1609012 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1999167-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR Novolen Technology Holdings, C.V. (NL) 2008-12-10 EP disclosed
WO-2007106348-A2 ZIEGLER-NATTA CATALYST WITH IN SITU-GENERATED DONOR NOVOLEN TECHNOLOGY HOLDINGS C.V. (NL) 2007-09-20 WO disclosed
US-20070213204-A1 Ziegler-Natta catalyst with in situ-generated donor NOVOLEN TECHNOLOGY HOLDINGS C.V. 2007-09-13 US disclosed